Menu

Three More Coauthors Removed from Macchiarini Paper

Colleagues of the surgeon under investigation distance themselves from a 2011 The Lancet study.

Apr 1, 2016
Kerry Grens

PIXABAY, PUBLICDOMAINPICTURESFollowing the example of Karl-Henrik Grinnemo, a surgeon at the Karolinska Institute, three more coauthors on a 2011 paper in The Lancet have asked to have their names removed from the publication. The senior author of the study, Paolo Macchiarini, has been accused of misconduct, fired from his job at the Karolinska institute, and is the subject of investigations into his work.

The three coauthors “no longer wish to be associated with this paper and ask for their names to be removed,” according to a March 31 correction notice. Twenty-three coauthors remain on the publication.                                                   

Macchiarini has been accused of breaching ethical standards relating to his work on artificial tracheas. The Royal Swedish Academy of Sciences flagged the 2011 study as concerning.

Update (April 1): The Lancet editors have now issued an expression of concern regarding the 2011 paper, Retraction Watch reported. "In view of the ongoing uncertainty about the integrity of the work reported in this paper, and after discussion with the lead author of the research artricle, Dr Paolo Macchiarini, we now issue an expression of concern about the paper, while reserving a final decision for when current investigations are completed," the editors wrote in the notice.

 

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.